Clinical evaluation of the usefulness of polyclonal and monoclonal antibodies raised against p65 protein in immunohistochemical diagnosis of breast cancer: A comparative study

Biomedical Letters

Volumn 54, Issue 216, 1996, Pages 223-231

  Niewiadomska, H ^a   Mirowski, M ^a,b   Stempien, M ^d   Blonski, J Z ^d   Hanausek, M ^c  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b SOLTAN INSTITUTE FOR NUCLEAR STUDIES   (Poland)

^c UNIVERSITY OF TEXAS   (United States)

^d NONE

Author keywords

Anti p65 antibody; Breast cancer; Oncofoetal protein

Indexed keywords

EID: 0030328128     PISSN: 0961088X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. BILIMORIA M. M. and Morrow M. 1995. The women at increased risk for breast cancer: evaluation and management strategies. CA Cancer J. Clin. 30A 263-78.
2. BLOOM H. J. G. and Richardson W. W. 1957. Histological grading and prognosis in breast cancer. A study of 1409 cases of which 359 have been followed for 15 years. Br. J. Cancer 11 359-77.
3. CONTEGIACOMO A., Alimandi M., Muraro R., Pizzi C., Carderopoli R., DeMarchis L., Sgambato A., Pettinato G., Petrella G., DeFilippo M-R. and Mariani-Constantini R. 1994. Expression of epitopes of the tumor-associated glycoprotein 72 and clinicopathological correlations in mammary carcinomas. Eur. J. Cancer 30A 813-20.
4. HANAUSEK M., Wang S., Błoński J. Z., Polkowska-Kulesza E., Walaszek Z. and Mirowski M. 1996. Expression of an oncofetal 65 kDa phosphoprotein in lymphocytic and granylocytic leukemias. Int. J. Haematol. 63 193-203.
5. HORAN HAND P., Nuti M., Cochler D. and Schlom J. 1983. Definition of antigenic heterogeneity and modulation among human mammary carcinoma cell population using monoclonal antibodies to tumor-associated antigens. Cancer Res. 43 728-35.
6. HSU S. M., Raine L. and Fanger H. 1981. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 29 577-80.
7. MIROWSKI M., Hanausek M., Sherman U., Adams A. K., Walaszek Z. and Slaga T. J. 1992. An enzyme-linked immunosorbent assay for p65 oncofetal protein and its potential as a new tumor marker for cancer risk assessment in rodents and humans. Prog. clin. Biol. Res. 374 281-94.
8. MIROWSKI M., Wakaszek Z., Sherman U. and Hanausek M. 1993. Comparative structural analysis of human and rat 65 kDa tumor-associated phosphoproteins. Int. J. Biochem. 25 1865-71.
9. MIROWSKI M., Klijanienko J., Wang S., Vielh P., Walaszek Z. and Hanausek M. 1994. Serological and immunohistochemical detection of a 65 kDa oncofetal protein in breast cancer. Eur. J. Cancer 30A 1108-13.
10. MIROWSKI M., Walaszek Z. and Hanausek M. 1996. Presence in bovine fetal serum of the protein antigenically related to p65-tumor associated antigen: its isolation and polyclonal antibody production. Neoplasma 43 83-8.
11. MIROWSKI M., Błon̈ski J. Z., Niewiadomska H., Ólborski B., Walaszek Z., Hanausek M. and Woźniak L. 1997a. Immunohistochemical study of 65 kDa oncofetal protein expression in breast cancer. Breast In press.
12. MIROWSKI M., Różalski M., Krajewska U., Hanausek M. and Wierzbicki R. 1997b. Expression of 65 kDa oncofetal protein in experimental hepatoma after anticancer therapy. Neoplasma 44 85-9.
13. WANG S., Mirowski M., Sherman U., Walaszek Z. and Hanausek M. 1993. Monoclonal antibodies against a 65 kDa tumor-associated phosphoprotein: development and use in cancer detection. Hybridoma 12 167-76.